Navigation Links
Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells
Date:1/24/2008

Appoints U.S. Biotest to Oversee Trials

PRINCETON, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has signed a clinical services agreement with San Luis Obispo-based, privately held U.S. Biotest, Inc. and will enter Phase II clinical development of DSC127, a novel and rapid wound-healing and scar-reduction product that has a unique mechanism of action potentially linked to the body's own, naturally occurring stem cells. The product has shown promising activity in pre-clinical animal models and has already been tested for safety in a Phase I study in humans.

Through DSC127, Derma Sciences will be able to position itself as a key player in the very large diabetic foot ulcer and scar reduction markets, two rapidly growing and global segments of the wound care market. In the U.S. there are an estimated 2.4 million diabetic foot ulcers and 60,000 diabetes-related amputations each year, which cost healthcare payers more than $10 billion. The market for an FDA-approved scar reduction treatment could reach as high as $4 billion annually in the U.S. alone.

The Phase II study for DSC127, which will be focused on diabetic foot ulcers, is scheduled to begin enrollment in the third quarter of 2008.

"The development of DSC127 is an important milestone for Derma Sciences because it represents an opportunity for us to enter two of the largest and fastest-growing wound care markets in the world today," said Ed Quilty, CEO of Derma Sciences. "Diabetes is a chronic medical issue around the globe and scar reduction, due in large part to the very rapid growth of cosmetic surgeries, is a significant new market for the wound care industry. These are the markets wound care needs to be focused on in the coming months and years and we believe DSC127, particularly due to its potential link to healing through the activation of stem cells
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
2. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
3. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
7. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
8. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...nd CHICAGO, Nov. 30 Today at the 9... Radiological Society of North America (RSNA), Ba...enrollment of the first patient in an internationa...y and safety of florbetaben (BAY 94-9172) PET imag...e brain, which are a pathological hallmark of Alzh...
(Date:11/30/2009)...IV, Israel, November 30 Optoacoust...) dual channel microphone, the most advanced,optic...etic resonance imaging,(fMRI) environments. ,... step forward for fiber,optic microphone technolog...h,low-latency adaptive noise cancelling. The FOMRI...
(Date:11/30/2009)...NAPOLIS, Nov. 30 The U.S...Cymbalta® (duloxetine HCl) for the maintenanc...in adults, Eli Lilly and Company (NYSE: LLY ) an...sorder can be a chronic illness, it is important t...tion that is effective in both the acute and maint...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During Septembers National Food Safety Education Mont 56107 1National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During Septembers National Food Safety Education Mont 56107 2OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 13814 1OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 13814 2Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 1Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 2Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 3Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 4
... MedImmune to Present Preclinical Data From Study ... Mass. and GAITHERSBURG, Md., April 10, 2007 (PRIM...daq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today ...an oral formulation of IPI-504 in non-small,cell l...ng Annual,Meeting of the American Association for ...
...d., April 10, 2007--In a study appearing in the Ma... supported by the,National Institutes of Healths N... and Skin Diseases (NIAMS) have discovered a,conne... skin,condition vitiligo, as well as a possible ho... condition in which melanocytes (the cells,that ma...
Other Medicine Technology:Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3
(Date:11/30/2009)..., Peter J. Rappa, MD, exp...d the body in his new book "Healing Heart to ...g, and Life" (Brown Books 2009). , ...9 -- Experiencing and refusing to let go of negat... others, can weigh heavy on our shoulders. Oftenti...
(Date:11/30/2009)..., , ENGLEWOOD, Colo., Nov. 30 /PRNew...ional presentation discussing what "culture of saf...idday Symposium presentation, "Creating a Culture...th-system professionals discussing their experienc...a culture of safety in pharmacy and the role of te...
(Date:11/30/2009)..., , ROCKLAND, Mass., Nov. 30 /PRNewswir...stadt, Germany, announced today that it received a...dministration (FDA) on the New Drug Application (N...ry investigational oral formulation of cladribine,...rosis (MS). ,, "The company will work closely ...
(Date:11/30/2009)..., , MINNEAPOLIS, Nov. 30 ...age and Supplemental Medicare insurance customers ...switch their Medicare coverage. The figure is up ...intention to switch" measure has been a leading in...everyone with some intention to switch actually wi...
(Date:11/30/2009)... Improved screening, awareness may help delay prog... , MONDAY, Nov. 30 (HealthDay News) -- Medic...States costs $185.5 billion a year, according to a....4 billion while patients pay $36.1 billion in out...per female patient and $4,036 per male patient. Wo...
Breaking Medicine News(10 mins):Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:More Seniors Considering Health Insurance Switch 2Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2
... Weight Loss, Proper Nutrition, and Fitness n...25,000 Max Muscle MaxFormation Life Challenge Ener.../ . , Anaheim, CA (PRWEB)...t of the $25,000 MaxFormation Life Challenge as it...
... When Physicians for Human Rights (PHR) relea...abwe,s health system collapse the reported cholera...y exceeds 3,000, according to the World Health Org...diplomacy to strengthen respect for human rights. ...
... AllHealthcarejobs.com, an Internet based med...d healthcare job seekers 4-fold in both 2007 and a...chieved very strong growth in website traffic - be...HealthcareJobs.com, an internet medical job bank s...
...gold nanospheres equipped with a targeting peptide...hen cook the tumor when bathed with near-infrared ...iversity of Texas M. D. Anderson Cancer Center rep...gy for cancer. We,re getting closer to that goal,"...
... Research at The Total Health Center shows th...creasing muscle mass without a major decrease in f...ruary 1, 2009 -- Scientists at The Total Health an...the Total Heath Center have released the prelimina...
... A study in the Feb. 1 issue of the journal SLEEP...nges in the levels of specific cytokines that are ... suggest that inflammation may be the pathway link...cent increase in C-reactive protein (CRP) levels a...
Other Medicine News:Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 2Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 3Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 4Health News:As Obama Urges Emergency Action on Zimbabwe, Health Crisis Worsens 2Health News:As Obama Urges Emergency Action on Zimbabwe, Health Crisis Worsens 3Health News:AllHealthcareJobs.com Achieves a 4-fold Growth for a Second Year in a Row 2Health News:AllHealthcareJobs.com Achieves a 4-fold Growth for a Second Year in a Row 3Health News:Targeted nanospheres find, penetrate, then fuel burning of melanoma 2Health News:Targeted nanospheres find, penetrate, then fuel burning of melanoma 3Health News:Study suggests that inflammation may be the link between extreme sleep durations and poor health 2
Cortex Extractor - Charleux
HydroExpression Cannula - Corydon
Hydrodissector - Pearce
Irrigating Cystotome
Medicine Products: